NICE says to restrict antibiotics in COPD

NICE says to restrict antibiotics in COPD

July 13 2018 Draft guidance is calling for health professionals to consider the risk of...

NICE updates guideline on rheumatoid arthritis

NICE updates guideline on rheumatoid arthritis

July 13 2018 NICE has issued a new version of its guideline on the management of rheumatoid...

Community pharmacy option for antihypertensives referral sees little increase in GP workload

Community pharmacy option for antihypertensives referral sees little increase in GP workload

July 11 2018 Community pharmacy referrals for hypertensive patients under the New Medicines...

CMO concludes cannabis products should move out of Schedule 1 classification

CMO concludes cannabis products should move out of Schedule 1 classification

July 9 2018 The Chief Medical Officer has recommended rescheduling cannabis-based products as...

GP partnership review invites views on how to reinvigorate the model

GP partnership review invites views on how to reinvigorate the model

July 6 2018 The Department of Health and Social Care has set out the lines of inquiry for the...

  • NICE says to restrict antibiotics in COPD

    NICE says to restrict antibiotics in COPD

    Friday, 13 July 2018 13:05
  • NICE updates guideline on rheumatoid arthritis

    NICE updates guideline on rheumatoid arthritis

    Friday, 13 July 2018 12:58
  • Community pharmacy option for antihypertensives referral sees little increase in GP workload

    Community pharmacy option for antihypertensives referral sees little increase in GP workload

    Wednesday, 11 July 2018 13:17
  • CMO concludes cannabis products should move out of Schedule 1 classification

    CMO concludes cannabis products should move out of Schedule 1 classification

    Monday, 09 July 2018 09:26
  • GP partnership review invites views on how to reinvigorate the model

    GP partnership review invites views on how to reinvigorate the model

    Friday, 06 July 2018 15:17

a spirometry image 2July 13 2018

Draft guidance is calling for health professionals to consider the risk of antimicrobial resistance when prescribing for chronic obstructive pulmonary disease (COPD).

NICE has said that prescribers need to decide whether antibiotics are really needed for treating or preventing a flare up of COPD symptoms.

The draft antimicrobial guidance recommends that antibiotics should be offered to people who have a severe acute exacerbation. However, “other factors should be taken into account when considering the use of antibiotics for treating an acute exacerbation that is not severe, such as the number and severity of symptoms,” said NICE.

Factors such as viral causes or smoking should be part of the prescribing assessment. In other cases, NICE is proposing the following: “Consider an antibiotic for people with an acute exacerbation of COPD that is not severe, but only after taking into account:

  • the number and severity of symptoms, bearing in mind that for people with less severe or fewer symptoms who are having treatment in the community there is evidence of uncertain benefit of antibiotics;
  • whether they need to go into hospital for treatment (see the NICE guideline on COPD);
  • previous exacerbation and hospital admission history, and the risk of developing complications;
  • previous sputum culture and susceptibility results;
  • the risk of antimicrobial resistance with repeated courses of antibiotics.”

NICE has also issued a separate update to its 2010 clinical guideline on diagnosing and managing COPD in over 16s.

Commenting on the proposed guidance, Professor Mark Baker, director of the centre for guidelines at NICE, said: “The evidence shows that there are limited benefits of using antibiotics for managing acute exacerbations of COPD and that it is important other options are taken into account before antibiotics are prescribed.

“The new guideline will help healthcare professionals make responsible prescribing decisions to not only help people manage their condition but also reduce the risk of resistant infections.”

The other draft clinical guideline update states when to use antibiotics to prevent exacerbations happening in the first place (antibiotic prophylaxis). “It recommends that antibiotics used in this way should only be offered to people who are most likely to benefit from them,” said NICE.

Links:
NICE announcement     
NICE: ‘Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing NICE guideline Draft for consultation July 2018’.      
NICE ‘Chronic obstructive pulmonary disease in over 16s: diagnosis and management (update)’ 

Professional News

July 13 2018 Draft guidance is calling for health professionals to consider the risk of antimicrobial resistance when prescribing for chronic obstructive pulmonary disease (COPD).
July 11 2018 Community pharmacy referrals for hypertensive patients under the New Medicines Service has not increased GP workload appreciably. Analysis of 131,419 patient records in England has...